Sino-British scientists cooperate to seek new drugs from Chinese medicine

According to the British "Times" reported on the 16th, a two-year Sino-British science and technology cooperation project will officially begin this month. Presided over the project * UK stem cell scientist Dr Stephen Minger will travel to Shanghai, China, will bring together the UK Alzheimer's disease research scientists and Chinese researchers hope to be able to dig out from traditional Chinese medicine to treat the condition in New drug .

Mingge said that if this project is successful, Chinese medicine may provide us with some drugs that have never been contacted before. Rebecca Wood, head of the Alzheimer's disease research institute in the UK, also believes that seeking a possible treatment from Chinese medicine will open up new avenues for treatment.

In recent years, the Chinese government has invested in research to extract conventional drugs from traditional Chinese medicine. Mingge said that China has been committed to research in this area and has a national laboratory specializing in Chinese medicine. Mingge pointed out that it is not easy to extract conventional drugs from traditional Chinese medicine. Because each Chinese medicine prescription contains a lot of traditional Chinese medicines, it is difficult to confirm whether it is a traditional Chinese medicine that plays a role, or a combination of several traditional Chinese medicines.

The research began with identifying a drug that might be effective. Scientists will use modern technology and exclusion methods to test the efficacy of each Chinese medicine in Chinese medicine, and remove the ineffective drugs until there are only a few chemical components left in the prescription.

Mingge said that for British scientists, scientific cooperation between China and the West is an important way to promote scientific progress. He believes that the Chinese medicine system based on energy flow in the body, balance of yin and yang, etc. can promote the development of Western medicine based on arguments.


Finished Products of varicella vaccine. It has three qualities,good safety of gelatin-free, long validity period by good stability, better protection with high titer and immune efficacy. These improvements enhanced the vaccine safety and quality, and established BCHT the leading position in varicella vaccine. We have two different packages, penicillin bottle and pre-filled syringe. And it has been exported to other countries, such as India, Philippines.
Penicillin BottlePre-filled

Finished Products

Finished Products Of Rabies Vaccine,Rabies Vaccine For Human Use,Live Biotechnology Chicken Pox,Live Lyophilized Vaccination

Changchun BCHT Biotechnology Co. , https://www.ccbcht.com